Isbn: 9798186706762 - i have cardiac amyloidosis: now what do i do?: a patient’s guide to the science, testing, and treatments transforming this disease (4 resultados)

ISBN: 
Refinar con la Búsqueda avanzada

Filtrar la búsqueda

  • Libros (4)

  • Nuevo (4)

a

Intervalo de precios personalizado (EUR)

a

  • Idioma: Inglés

    Editorial: CreateSpace Independent Publishing Platform, 2026

    9798186706762

    • Tapa blanda

    Librería: PBShop.store UK, Fairford, GLOS, Reino UnidoPBShop.store UK

    Vendedor de 5 estrellas
    Contactar con el vendedor

    Condición: Nuevo

    EUR 13,04

    Envío por EUR 3,84 
    Se envía de Reino Unido a Estados Unidos de America

    Cantidad disponible: Más de 20 disponibles

    PAP. Condición: New. New Book. Shipped from UK. Established seller since 2000.

  • Idioma: Inglés

    Editorial: Independently Published, 2026

    9798186706762

    • Tapa blanda
    • Impresión bajo demanda

    Librería: Grand Eagle Retail, Bensenville, IL, Estados Unidos de AmericaGrand Eagle Retail

    Vendedor de 5 estrellas
    Contactar con el vendedor

    Condición: Nuevo

    EUR 17,36

     Gastos de envío gratis 
    Se envía dentro de Estados Unidos de America

    Cantidad disponible: 1 disponible

    Paperback. Condición: new. Paperback. Written by a U.S. board-certified cardiologist, for patients and families who just heard the word "amyloidosis" for the first time.A cardiac amyloidosis diagnosis raises more questions than any single doctor's appointment can answer. What actually is this disease? Is it the AL kind or the ATTR kind - and does that difference matter? Why does everyone keep asking about carpal tunnel surgery? Which of the new drugs is right for you, and what will it actually cost? What can you still do - travel, exercise, work - and what should you watch for?This guide answers all of it, in plain language, without talking down to you.Inside, you'll find: - A clear explanation of what cardiac amyloidosis is, how AL and ATTR differ, and why this disease - once considered vanishingly rare - is now recognized in a meaningful share of older adults with unexplained heart failure- The full diagnostic pathway explained step by step: blood and urine tests, the PYP scan, genetic testing, and what your specific results actually mean- An in-depth look at every FDA-approved treatment - tafamidis, acoramidis, vutrisiran, and more - including how stabilizers and silencers work differently, and how to think through the choice with your cardiologist- A realistic, current picture of the research pipeline: gene editing, new PET tracers, and amyloid-clearing antibodies, explained with both the promise and the real safety history- Straight talk about drug costs, Medicare coverage, and the assistance programs that bring six-figure list prices down to what most patients actually pay- A full chapter on medications to avoid or use with caution - because several drugs that are completely standard in other heart conditions are not safe here- A dedicated emergency chapter: exactly when to call your doctor versus go straight to the ER- Practical, day-to-day guidance most patient guides skip - diet, exercise, travel, sleep, intimacy, orthostatic hypotension, caregiver burnout, and advance care planning- Recurring patient stories that show how these concepts play out in real life- A complete glossary, doctor-visit worksheets, a daily symptom tracker, and QR codes linking directly to major patient organizations This item is printed on demand. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.…

  • Idioma: Inglés

    Editorial: Independently published, 2026

    9798186706762

    • Tapa blanda
    • Impresión bajo demanda

    Librería: California Books, Miami, FL, Estados Unidos de AmericaCalifornia Books

    Vendedor de 5 estrellas
    Contactar con el vendedor

    Condición: Nuevo

    EUR 18,17

     Gastos de envío gratis 
    Se envía dentro de Estados Unidos de America

    Cantidad disponible: Más de 20 disponibles

    Condición: New. Print on Demand.

  • Idioma: Inglés

    Editorial: Independently Published, 2026

    9798186706762

    • Tapa blanda
    • Impresión bajo demanda

    Librería: CitiRetail, Stevenage, Reino UnidoCitiRetail

    Vendedor de 5 estrellas
    Contactar con el vendedor

    Condición: Nuevo

    EUR 16,81

    Envío por EUR 43,16 
    Se envía de Reino Unido a Estados Unidos de America

    Cantidad disponible: 1 disponible

    Paperback. Condición: new. Paperback. Cardiac amyloidosis has gone, in less than a decade, from a disease usually found at autopsy to one with three FDA-approved therapies, a diagnostic pathway that usually avoids biopsy entirely, and an active pipeline that includes CRISPR gene editing. Written by a board-certified cardiologist, this guide walks patients and families through everything they need to understand: the difference between AL and ATTR amyloidosis, the red-flag symptoms (carpal tunnel, spinal stenosis, neuropathy) that are often missed for years, how the PYP scan lets most patients skip a heart biopsy, all three currently approved ATTR-CM medications and how they compare, the honest state of emerging therapies including a frank look at the 2025 safety pause on CRISPR gene editing, real 2026 drug pricing and Medicare/insurance coverage pathways, and practical day-to-day guidance for living well with this diagnosis. This book is for general education and does not replace the individualized advice of your own physician. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.…